Talazoparib + Enzalutamide seems to b... - Fight Prostate Ca...

Fight Prostate Cancer

2,949 members1,290 posts

Talazoparib + Enzalutamide seems to be the best combo: post hoc analysis

Maxone73 profile image
9 Replies

A statistical method, Matching-Adjusted Indirect Comparison (MAIC), has been used to evaluate the effectiveness of different PARP inhibitor combinations for treating metastatic castration-resistant prostate cancer (mCRPC).

The study, published on Nature, found that a combination of talazoparib and enzalutamide (TALA + ENZA) may be more effective than other PARP inhibitor combinations, such as olaparib plus abiraterone acetate and niraparib plus abiraterone acetate. TALA + ENZA was found to slow cancer progression, particularly in patients with homologous recombination repair mutations.

The combination also showed a better PSA response compared to olaparib plus abiraterone acetate. However, the article acknowledges the limitations of indirect comparisons and emphasizes the need for further research.

prostatewarriors.com/2024/1...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
9 Replies
KocoPr profile image
KocoPr

i wonder what the time to resistance is?

j-o-h-n profile image
j-o-h-n

WE

Good Luck, Good Health and Good Humor.

j-o-h-n

Maxone73 profile image
Maxone73 in reply toj-o-h-n

I miss you too guys, especially not being able to contribute my two cents

Seasid profile image
Seasid

Could you come back?

Maxone73 profile image
Maxone73 in reply toSeasid

I have been banned, but I can still read you guys

Seasid profile image
Seasid

I know that you are banned but could you ask them to take you back?

Maxone73 profile image
Maxone73 in reply toSeasid

If they have banned me they must have had a good reason, which of course they did not have the guts to explain publicly (as they have deleted my post where I was simply stating that i would have contributed my articles here and not on APC and telling my friends that yhey could always find me here). They limited themselves to define me as someone who built a little credibility on their community and then wanted to exploit it for personal gains.

cujoe profile image
cujoe in reply toMaxone73

Restrictions and deletions elsewhere are purely to preserve the staus quo and cash flow.

Maxone73 profile image
Maxone73 in reply toSeasid

And I was asked few months ago, by the same person who banned me, to contribute (for free of course) to a new project with my articles. How ironic. As I stated when health unlocked contacted me after I was banned, my website is just a repository, not a community, so there was no direct competition with APC...but still...

Not what you're looking for?

You may also like...

FDA Grants Priority Review to Olaparib for HRR-Mutant mCRPC - Targeted Oncology - January 20, 2020

The FDA has granted a Priority Review to the New Drug Application for olaparib (Lynparza) as...
cujoe profile image

EMBARK Study: Enzalutamide +/- ADT

Results of the EMBARK study was published this week (10/19/23) in NEJM. It compared high risk BCR...

The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) meeting-- Chock full of Testosterone...

Greetings FPC Forum Dwellers, Marnie passed me some solid information on the APCCC...and it is all...
NPfisherman profile image

Evidence that the Medical Community is Failing Prostate Cancer Patients !!

Greetings FPC'ers, So I saw this on Advanced Practice Update and just had to share. When the K9...
NPfisherman profile image